<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Virology</title>
<title_fa>مجله ویروس شناسی ایران</title_fa>
<short_title>Iran J Virol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.isv.org.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1735-5680</journal_id_issn>
<journal_id_issn_online>2588-5030</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.21859/isv</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1392</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2014</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>8</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Comparison between interleukine-17 levels by NK-T cells in patients with chronic hepatitis C and healthy individuals</title>
	<subject_fa>تخصصي</subject_fa>
	<subject>Special</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-bottom: 0.0001pt line-height: 150%&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;Background and Aims:&lt;/span&gt;&lt;/b&gt; &lt;span style=&quot;font-size: 12pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;Natural killer T (NKT) cells have&lt;/span&gt;&lt;span dir=&quot;rtl&quot; style=&quot;font-size: 12pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt; &lt;/span&gt;&lt;span style=&quot;font-size: 12pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;been suggested to play critical roles in a wide range&lt;/span&gt;&lt;span dir=&quot;rtl&quot; style=&quot;font-size: 12pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt; &lt;/span&gt;&lt;span style=&quot;font-size: 12pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;of immune responses especially against hepatotropic pathogens such as hepatitis C virus (HCV). In&amp;nbsp; the&amp;nbsp; present&amp;nbsp; study,&amp;nbsp; we&amp;nbsp; investigated&amp;nbsp; the&amp;nbsp; status&amp;nbsp; of&amp;nbsp; NKT&amp;nbsp; cells&amp;nbsp; by producing interleukin-17 cytokine in&amp;nbsp; peripheral&amp;nbsp; blood.&lt;/span&gt;&lt;span style=&quot;font-size: 10pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-bottom: 0.0001pt line-height: 150%&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;Patients and Methods:&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;font-size: 12pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;As case-control study, 15 patients with chronic HCV infection and healthy individuals were enrolled in the study. We was determined the serum and peripheral blood IL-17 levels after activating by based on Galactosylceramid and IL-2 then the IL-17 level was measured by Enzyme-linked immunisorbentassey (ELISA) methods. &lt;/span&gt;&lt;/p&gt;

&lt;p class=&quot;p&quot; style=&quot;margin: 0cm 0cm 0.0001pt line-height: 150%&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt line-height: 150%&quot;&gt;Results: &lt;/span&gt;&lt;/b&gt;Plasma level of IL-17 in patients with chronic infection did not differ compared to the control group (5.5&amp;plusmn;2.4 vs. 6.2&amp;plusmn;1.2 pg/ml p=0.5). The level of supernatant IL-17 was significantly increased in both Galactosylceramid-IL-2-stimulated PBMCs than control group that ratio IL-17 after 72 h was higher than other times. The plasma level of IL-17 in HCV 3a-infected patients was higher than 1a-type patients that this difference was not significant (6&amp;plusmn;2.5 vs. 4.8&amp;plusmn;2.5 p=0.45).&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;line-height: 150%&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size: 10pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;Conclusion&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size: 10pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;: &lt;/span&gt;&lt;span style=&quot;font-size: 12pt line-height: 150% font-family: 'Times New Roman', serif&quot;&gt;As the recent data, the roles of NKT cells in human liver injury and fibrosis remain unknown. However, the precise role of NKT cells in HCV patients as this play a role in innate immune responses in the liver in higher samples was performed.&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>NKT cells, hepatitis C virus, Th17 cells,  </keyword>
	<start_page>6</start_page>
	<end_page>11</end_page>
	<web_url>http://journal.isv.org.ir/browse.php?a_code=A-10-78-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Ahmad</first_name>
	<middle_name></middle_name>
	<last_name>Najafi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ahmad.najafi.2012@gmail.com</email>
	<code>10031947532846003248</code>
	<orcid>10031947532846003248</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ali</first_name>
	<middle_name></middle_name>
	<last_name>Shams</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>alis743@yahoo.com</email>
	<code>10031947532846003249</code>
	<orcid>10031947532846003249</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Abbas</first_name>
	<middle_name></middle_name>
	<last_name>Ahmadi Vasmehjani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>a.ahmadi.tums.ac@gmail.com</email>
	<code>10031947532846003250</code>
	<orcid>10031947532846003250</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Amir</first_name>
	<middle_name></middle_name>
	<last_name>Hossein Mansourabadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ahvasmehjani@gmail.com</email>
	<code>10031947532846003251</code>
	<orcid>10031947532846003251</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
